NCT03422523 2022-08-22ARGOUniversity Hospital Southampton NHS Foundation TrustPhase 2 Terminated53 enrolled
NCT03488251 2022-08-16PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's LymphomaMolecular Templates, Inc.Phase 2 Terminated8 enrolled 9 charts
NCT00101205 2014-02-24Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Terminated40 enrolled